Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+625K
-
Total reported value, excl. options
-
$1.59B
-
Value change
-
+$20.5M
-
Put/Call ratio
-
1.17
-
Number of buys
-
116
-
Number of sells
-
-89
-
Price
-
$29.16
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2021
259 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
of 56M outstanding shares and own 97.54% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.45M shares), VANGUARD GROUP INC (5.51M shares), ARMISTICE CAPITAL, LLC (4.14M shares), DIMENSIONAL FUND ADVISORS LP (2.24M shares), MACQUARIE GROUP LTD (2.17M shares), GW&K Investment Management, LLC (1.84M shares), STATE STREET CORP (1.78M shares), LOOMIS SAYLES & CO L P (1.67M shares), Stephens Investment Management Group LLC (1.58M shares), and Aristotle Capital Boston, LLC (1.29M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.